TKT and neoplasm: Recently, we described a novel VVLΔTKΔN1L with thymidine kinase (TK) and N1L gene deletion, which demonstrated a stronger antitumor effect and activated stronger antitumor immunity in different tumor models, compared with N1L-intact VVLΔTK.13